Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science

Launched by FUDAN UNIVERSITY · Oct 16, 2023

Keywords

ClinConnect Summary

This clinical trial, called "ICU-NO CRBSI," is focused on preventing a type of infection known as Catheter-Related Bloodstream Infection (CRBSI) in patients who are in the Intensive Care Unit (ICU). The study aims to improve the quality of care by using evidence-based practices to ensure that healthcare providers follow the best methods for keeping central venous catheters (thin tubes placed in large veins) safe and clean. Researchers will look at how often these infections happen and how well staff are following safety guidelines.

To be eligible for this trial, patients need to be staying in the ICU for more than 48 hours and must have had a central venous catheter in place for more than 24 hours. Unfortunately, pregnant patients and those with a history of CRBSI or who had their catheter placed at another hospital cannot participate. If you or a family member are eligible, you can expect to receive standard care along with additional support aimed at improving safety and quality during the ICU stay. The trial is currently recruiting participants, and your involvement can help enhance the care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ICU stay over 48 hours
• • CVC was placed for more than 24 hours
• Exclusion Criteria:
• • Pregnant patients
• • Patients with a history of CRBSI infection
• • Patients with central venous catheterization were brought in from other hospitals